サイト内検索


登録済み会員ログイン




未登録の方はこちらから登録できます。
新規会員登録


ご利用案内

ご利用案内


連絡先

TEL.03-5812-5270
FAX.03-3831-0495
E-mail:info@spi-information.com


関連サイト・サービス

市場調査のご依頼、専門分野のイベント・フォーラムの開催などは シード・プランニングにて承っております。

シードプランニング

世界の医療・医薬品産業レポートのデータベースサービスは、sekairyo.comにてご利用いただけます。

sekairyo.com

医療従事者へのあらゆる形態の調査は、メドサークルにお任せ下さい。

メドサークル


セキュリティについて

当サイトのコンテンツ利用時に送信される機密情報は、Verisign認証の元暗号化されて送信されます。


Mycoplasma Testing Market - Global Forecast to 2022

マイコプラズマ検査市場-2022年までの世界予測

レポート概要

マイコプラズマ検査市場:製品&サービス別(キット&試薬、器具)、技術別(PCR、ELSA、酵素法、DNA染色、用途別(細胞株検査、ウイルス検査)、エンドユーザー別(製薬企業、細胞バンク)-2022年までの世界予測

マイコプラズマ検査市場は2017年の5億2,330万ドルから2022年までに9億4,340万ドルに達する見込みです。

マイコプラズマ検査市場における主な市場動態

ライフサイエンスにおける堅調な研究開発投資動向

医薬品、バイテク企業はブレイクスルーにつながる分子を開発するために研究への投資を推進

がん、糖尿病、心血管疾患といった生命を脅かす疾患に対する治療ニーズが高まっていることから、新薬を開発するための更なる研究が必要となっています。

Battelle(米国)によると、2014年における世界のライフサイエンス産業の研究開発費は総額約2,013億ドルでした。R&D Magazineが発表した予測によると、2016年における世界のライフサイエンスに関連した研究開発費は2015年と比較して1.8%増の1,693億ドルに達しています。ドイツでは2015年の研究開発費が10億4,000万ドルに増加しました。人件費と研究開発投資の増加がその要因です。

レポート詳細

目次

Table of Contents

1 Introduction (Page No. - 15)
1.1 Objectives of the Study
1.2 Market Definition
1.3 Market Scope
1.3.1 Market Covered
1.3.2 Years Considered for the Study
1.4 Currency
1.5 Limitations
1.6 Stakeholders

2 Research Methodology (Page No. - 18)
2.1 Secondary Data
2.1.1 Key Data From Secondary Sources
2.2 Primary Data
2.2.1 Key Data From Primary Sources
2.3 Market Size Estimation
2.3.1 Bottom-Up Approach
2.3.2 Top-Down Approach
2.4 Market Breakdown & Data Triangulation
2.5 Assumptions for the Study

3 Executive Summary (Page No. - 26)

4 Mycoplasma Testing Market: Premium Insights (Page No. - 31)
4.1 Mycoplasma Testing: Market Overview
4.2 Geographic Analysis: By Application (2017)
4.3 By Product and Service, 2017-2022
4.4 Geographical Snapshot of the global market

5 Market Overview (Page No. - 34)
5.1 Introduction
5.2 Market Dynamics
5.2.1 Drivers
5.2.1.1 Increasing Growth and Government Support for Pharmaceutical and Biotechnology Industries
5.2.1.2 Strong Trend of R&D Investments in Life Sciences
5.2.1.3 Cell Culture Contamination—A Major Concern for Laboratories
5.2.2 Restraints
5.2.2.1 High Degree of Consolidation Acts as an Entry Barrier for New Entrants
5.2.2.2 Stringent Regulatory Frameworks and Time-Consuming Approval Processes for Pharmaceutical and Biotechnology Companies
5.2.3 Opportunity
5.2.3.1 Increasing Pharmaceutical Outsourcing
5.2.4 Challenge
5.2.4.1 Shortage of Skilled Professionals

6 Mycoplasma Testing Market, By Product & Service (Page No. - 39)
6.1 Introduction
6.2 Kits & Reagents
6.2.1 PCR Assays
6.2.2 Nucleic Acid Detection Kits
6.2.3 Elimination Kits & Reagents
6.2.4 Stains
6.2.5 Standards & Controls
6.2.6 Other Kits & Reagents
6.3 Instruments
6.4 Services

7 Mycoplasma Testing Market, By Technique (Page No. - 48)
7.1 Introduction
7.2 PCR
7.3 Elisa
7.4 Direct Assays
7.5 Indirect Assays
7.6 Dna Staining
7.7 Microbial Culture Techniques
7.8 Enzymatic Methods

8 Mycoplasma Testing Market, By Application (Page No. - 54)
8.1 Introduction
8.2 Cell Line Testing
8.3 Virus Testing
8.4 End-Of-Production Cell Testing
8.5 Other Applications

9 Mycoplasma Testing Market, By End User (Page No. - 60)
9.1 Introduction
9.2 Pharmaceutical and Biotechnology Companies
9.3 Contract Research Organizations
9.4 Academic Research Institutes
9.5 Cell Banks
9.6 Other End Users

10 Geographic Analysis (Page No. - 67)
10.1 Introduction
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 U.K.
10.3.3 France
10.3.4 Italy
10.3.5 Spain
10.3.6 Rest of Europe (RoE)
10.4 Asia
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 Rest of Asia (RoA)
10.5 Rest of the World (RoW)

11 Competitive Landscape (Page No. - 104)
11.1 Introduction
11.2 Vendor Dive Overview
11.2.1 Vanguards
11.2.2 Innovators
11.2.3 Dynamic
11.2.4 Emerging
11.3 Competitive Benchmarking
11.3.1 Analysis of Product Portfolio of Major Players in Mycoplasma Teting Market (25 Players)
11.3.2 Business Strategies Adopted By Major Players in the Mycoplasma Testing Market(25 Players)

*Top 25 Companies Analyzed for This Studies are - Charles River Laboratories International, Inc.(U.S.), Merck KGaA (Germany),Roche Diagnostics ( Switzerland), Lonza Group Ltd. (Switzerland), SGS S.A. (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), American Type Culture Collection (U.S.), Bionique Testing Laboratories, Inc. (U.S.),Invivogen (U.S.), Promo Cell GmbH (Germany), Biological Industries Israel Beit Haemek Ltd, Wuxi Apptec.(U.S.), Norgen Biotek Corp.(Canada), Agilent Technologies (U.S.), Biotools, B & M Labs, S.A.(Spain), Eurofins Scientific (Luxembourg), Gibraltar Laboratories(U.S.), Genecopoeia Inc.(U.S.), Genbio(Canada), Hylabs(Israel), Minerva Biolabs GmbH (Germany), Meridian Bioscience, Inc.(U.S.), Sartorius AG (Germany), Savyon Diagnostics(Israel), Sciencell Research Laboratories, Inc.(Canada)

12 Company Profiles (Page No. - 108)
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
12.1 Charles River Laboratories International, Inc.
12.2 Merck KGaA
12.3 Lonza Group Ltd.
12.4 Roche Diagnostics (Division of F. Hoffman-LA Roche Ltd.)
12.5 SGS S.A.
12.6 Thermo Fisher Scientific Inc.
12.7 American Type Culture Collection
12.8 Biounique Testing Laboratories Inc.
12.9 Invivogen
12.10 Promocell GmbH
12.11 Biological Industries Israel Beit Haemek Ltd.
12.12 Wuxi Apptec
12.13 Norgen Biotek Corporation

*Details on Marketsandmarkets View, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments Might Not Be Captured in Case of Unlisted Companies.

13 Appendix (Page No. - 146)
13.1 Industry Insights
13.2 Discussion Guide
13.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
13.4 Introducing RT: Real-Time Market Intelligence
13.5 Available Customizations
13.6 Related Reports
13.7 Author Details

List of Tables (73 Tables)
Table 1 Mycoplasma Testing: Market Snapshot
Table 2 Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 3 Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022(USD Million)
Table 4 Mycoplasma Testing Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 5 PCR Assays Market Size, By Region, 2015-2022 (USD Million)
Table 6 Nucleic Acid Detection Kits Market Size, By Region, 2015-2022 (USD Million)
Table 7 Elimination Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 8 Mycoplasma Testing Stains Market Size, By Region, 2015-2022 (USD Million)
Table 9 Standards & Controls Market Size, By Region, 2015-2022 (USD Million)
Table 10 Other Kits & Reagents Market Size, By Region, 2015-2022 (USD Million)
Table 11 Mycoplasma Testing Instruments Market Size, By Region, 2015-2022 (USD Million)
Table 12 Mycoplasma Testing Services Market Size, By Region, 2015-2022 (USD Million)
Table 13 Market Size, By Technique, 2015-2022 (USD Million)
Table 14 Market Size for PCR, By Region, 2015-2022 (USD Million)
Table 15 Elisa Method Market Size, By Region, 2015-2022 (USD Million)
Table 16 Direct Assays Market Size, By Region, 2015-2022 (USD Million)
Table 17 Indirect Assays Market Size, By Region, 2015-2022 (USD Million)
Table 18 Dna Staining Market Size, By Region, 2015-2022 (USD Million)
Table 19 Microbial Culture Techniques Market Size, By Region, 2015- 2022 (USD Million)
Table 20 Enzymatic Methods Market Size, By Region, 2015-2022 (USD Million)
Table 21 Mycoplasma Testing Market Size, By Application, 2015-2022 (USD Million)
Table 22 Market Size for Cell Line Testing, By Region, 2015-2022 (USD Million)
Table 23 Market Size for Virus Testing, By Region, 2015-2022 (USD Million)
Table 24 Market Size for End-Of-Production Cell Testing, By Region, 2015-2022 (USD Million)
Table 25 Other Mycoplasma Testing Applications Market Size, By Region, 2015-2022 (USD Million)
Table 26 Market Size, By End User, 2015-2022 (USD Million)
Table 27 Market Size for Pharmaceutical and Biotechnology Companies, By Region, 2015-2022 (USD Million)
Table 28 Market Size for Contract Research Organizations, By Region, 2015-2022 (USD Million)
Table 29 Market Size for Academic Research Institutes, By Region, 2015-2022 (USD Million)
Table 30 Market Size for Cell Banks, By Region, 2015-2022 (USD Million)
Table 31 Mycoplasma Testing Market Size for Other End Users, By Region, 2015-2022 (USD Million)
Table 32 Market Size, By Region, 2015-2022 (USD Million)
Table 33 North America: Mycoplasma Testing Market Size, By Country, 2015-2022 (USD Million)
Table 34 North America: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 35 North America: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 36 North America: Market Size, By Technique, 2015-2022 (USD Million)
Table 37 North America: Market Size, By Application, 2015-2022 (USD Million)
Table 38 North America: Market Size, By End User, 2015-2022 (USD Million)
Table 39 U.S.: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 40 U.S.: Market Size, By Technique, 2015-2022 (USD Million)
Table 41 U.S.: Market Size, By Application, 2015-2022 (USD Million)
Table 42 U.S.: Market Size, By End User, 2015-2022 (USD Million)
Table 43 Canada: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 44 Canada: Market Size, By Technique, 2015-2022 (USD Million)
Table 45 Canada: Market Size, By Application, 2015-2022 (USD Million)
Table 46 Canada: Market Size, By End User, 2015-2022 (USD Million)
Table 47 Europe: Market Size, By Country, 2015-2022 (USD Million)
Table 48 Europe: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 49 Europe: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 50 Europe: Market Size, By Technique, 2015-2022 (USD Million)
Table 51 Europe: Market Size, By Application, 2015-2022 (USD Million)
Table 52 Europe: Market Size, By End User, 2015-2022 (USD Million)
Table 53 Germany: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 54 U.K.: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 55 France: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 56 Italy: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 57 Spain: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 58 RoE: Mycoplasma Testing Market Size, By Product & Service, 2015-2022 (USD Million)
Table 59 Asia: Mycoplasma Testing Market Size, By Country, 2015-2022 (USD Million)
Table 60 Asia: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 61 Asia: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 62 Asia: Market Size, By Technique, 2015-2022 (USD Million)
Table 63 Asia: Market Size, By Application, 2015-2022 (USD Million)
Table 64 Asia: Market Size, By End User, 2015-2022 (USD Million)
Table 65 China: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 66 Japan: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 67 India: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 68 RoA: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 69 RoW: Market Size, By Product & Service, 2015-2022 (USD Million)
Table 70 RoW: Mycoplasma Testing Kits & Reagents Market Size, By Type, 2015-2022 (USD Million)
Table 71 RoW: Market Size, By Technique, 2015-2022 (USD Million)
Table 72 RoW: Market Size, By Application, 2015-2022 (USD Million)
Table 73 RoW: Market Size, By End User, 2015-2022 (USD Million)

List of Figures (36 Figures)
Figure 1 Global Mycoplasma Testing Market Segmentation
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Bottom-Up Approach
Figure 5 Top-Down Approach
Figure 6 Data Triangulation Methodology
Figure 7 Market Size, By Product and Service, 2017 vs 2022 (USD Million)
Figure 8 Mycoplasma Testing Kits and Reagents Market Size, By Type, 2017 vs 2022 (USD Million)
Figure 9 Market Size, By Technique, 2017 vs 2022 (USD Million)
Figure 10 Market Size, By Application, 2017 vs 2022 (USD Million)
Figure 11 Market Size, By End User, 2017 vs 2022 (USD Million)
Figure 12 Market Size, By Region, 2017 vs 2022 (USD Million)
Figure 13 Growing Pharmaceutical and Biotechnological Industries—Major Factor Driving Market Growth
Figure 14 Cell Line Testing Segment to Command the Largest Market Share in 2017
Figure 15 Services Segment to Register the Highest CAGR During the Forecast Period
Figure 16 Asia to Register the Highest CAGR Between 2017 & 2022
Figure 17 Mycoplasma Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 18 Kits & Reagents is Expected to Command the Largest Share of the Market in 2017
Figure 19 Global Market, By Technique
Figure 20 Cell Line Testing Will Be the Fastest-Growing Application Segment Durng Forecast Period
Figure 21 Pharmaceutical & Biotechnology Companies Segment to Dominate the Market in 2017
Figure 22 Asia to Register the Highest CAGR During the Forecast Period
Figure 23 U.S. to Dominate the North American Market in 2022
Figure 24 North America: Mycoplasma Testing Market Snapshot
Figure 25 Europe: Market Snapshot
Figure 26 Germany to Register the Highest CAGR in the European Market During the Forecast Period
Figure 27 China Will Continue to Dominate the Asian Market in 2022
Figure 28 Asia: Market Snapshot
Figure 29 RoW: Mycoplasma Testing Market Snapshot
Figure 30 Dive Chart
Figure 31 Charles River Laboratories International, Inc.: Company Snapshot (2016)
Figure 32 Merck KGaA: Company Snapshot (2016)
Figure 33 Lonza Group Ltd.: Company Snapshot (2016)
Figure 34 F. Hoffmann-LA Roche Ltd.: Company Snapshot (2016)
Figure 35 SGS S.A.: Company Snapshot (2016)
Figure 36 Thermo Fisher Scientific Inc.: Company Snapshot (2016)

発刊日

2019/11

体裁

PDF / 156ページ

販売価格

4,950USD

発行

MarketsandMarkets

備考

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※販売価格はシングルユーザーライセンスのものとなります。他のライセンス形態・価格に関しましてはご相談下さい。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

関連カテゴリ

バイオ・ゲノム・再生医療 / 診断・検査薬 / 医療器具・機器

購入・お問い合わせ

このレポートを購入

詳細を問い合わせる


PAGE